The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Martin H. Cohen

Division of Oncology Drug Products

Center for Drug Evaluation and Research

U.S. Food and Drug Administration

Rockville

USA

[email]@cder.fda.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, USA. 2001 - 2002
  • Division of Oncology Drug Products (HFD-150), Center for Drug Evaluation and Research and Office of Orphan Products Development, Office of the Commissioner, Food and Drug Administration, USA. 2002

References

  1. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer. Cohen, M.H., Johnson, J.R., Li, N., Chen, G., Pazdur, R. Clin. Cancer Res. (2002) [Pubmed]
  2. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. Cohen, M.H., Williams, G., Johnson, J.R., Duan, J., Gobburu, J., Rahman, A., Benson, K., Leighton, J., Kim, S.K., Wood, R., Rothmann, M., Chen, G., U, K.M., Staten, A.M., Pazdur, R. Clin. Cancer Res. (2002) [Pubmed]
  3. Gleevec for the treatment of chronic myelogenous leukemia: US. Food and Drug Administration regulatory mechanisms, accelerated approval, and orphan drug status. Cohen, M.H., Moses, M.L., Pazdur, R. Oncologist (2002) [Pubmed]
  4. U.S. Food and Drug Administration drug approval summaries: imatinib mesylate, mesna tablets, and zoledronic acid. Cohen, M.H., Dagher, R., Griebel, D.J., Ibrahim, A., Martin, A., Scher, N.S., Sokol, G.H., Williams, G.A., Pazdur, R. Oncologist (2002) [Pubmed]
  5. Drug approval summaries: arsenic trioxide, tamoxifen citrate, anastrazole, paclitaxel, bexarotene. Cohen, M.H., Hirschfeld, S., Flamm Honig, S., Ibrahim, A., Johnson, J.R., O'Leary, J.J., White, R.M., Williams, G.A., Pazdur, R. Oncologist (2001) [Pubmed]
 
WikiGenes - Universities